↑  Read the latest from the desks  ·  fresh intelligence, published daily✦Quiet reading✦No ads, ever

✦Corporate brand & media services✦Made in Virginia Beach since 1997✦

agilon health: Old boat (three warning signs)Old boat

agilon health $AGL

Saw revenue fall 2.1% in FY2025 to $5.9 billion, operating margin -7.8% against a 2.0% median for misc health & allied services, equity 10.0% of assets.

Last filing8-K · Item 7.01 Regulation FD Disclosure, 16 Nov 2026

Next year, 80%$5.0B–$9.1B
Growth, on the year−2.1%
Operating margin−7.8%
Equity of assets10.0%
Credibility50%
Track record0 of 3
Your call, sealedNext year’s revenue, your range. Sealed now, graded when the annual report lands.
Edgarette’s full reading · exposure, experience, soundness, credibility, range

🫧 Edgar looked up agilon health, inc. ($AGL). Last filing: 8-K (7.01 Regulation FD Disclosure), 2026-11-16. 12 event filings (8-K) in the past twelve months.

🔖 Exposure: revenue $5.9B (FY2025), total debt $35.0M. Experience: revenue down 2.1% on the year, up 40.5% a year over 4 years; operating margin -7.8%, down from -4.8%. Soundness: equity 10.0% of assets, return on equity -308.8%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $5.0B and $9.1B next year (method v4.1: its own 4-year record of growth weighed at 50% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $4.1B to $11.3B. A statistical range, not company guidance. Against peers (54 filers, $50M+ revenue, its industry group): operating margin -7.8% against a 2.0% median; growth -2.1% against 13.0%.

Read from its own SEC filings · nothing written, nothing inferred

agilon health, inc. against its own record and its peers
Operating marginPeer median 2.0%-7.8%Revenue, on the yearPeer median 13.0%-2.1%Equity of assetsPeer median 44.2%10.0%Return on equityPeer median 1.6%-308.8%Gold tick: the median of 49–59 peers with $50M+ revenue in services-misc health & allied services, nec

Speed and cash · fiscal 2025

Cash Compass⚡ Fast, cash not yet · growing fast, but little cash arriving so far
Inside viewTurns -1.8% of revenue into operating cash; revenue growing 35.4% a year over three years; no common dividend.
Outside viewAmong $1B-10B companies: 5th percentile for cash, 96th for growth. cash growth

Both views must agree for a label · a description, not advice.

Cash flow (op · inv · fin · free)−$106M · $89M · −$3M · −$119M
Investment book (cash · short · long)$174M · $58M · — · current ratio 1.02 · unrealized $1M
Revenue swing · equity of assets26.2% · 10.0%

agilon health is growing faster than its size class, with revenue that swings more. Its own audited SEC figures.

The figures, as filed

Fiscal year end2025-12-31
Revenue$5.9B
Revenue, on the year−2.1%
Revenue, a year over the record40.5%
Operating margin−7.8%
Operating margin, prior year−4.8%
Net margin−6.6%
Research and developmentnot filed separately
Total debt$35M
Equity of assets10.0%
Return on equity−308.8%
Payout of profit—
Dividend per share—
Earnings per share—
Book value per share$0.31
Revenue per share$14.33
Shares outstanding413,969,000
Audited years read5

Peers: the median of 54 filers with $50M+ revenue in services-misc health & allied services, nec.

Classic signals · fiscal 2025Altman Z″ -7.3 distress zone 1968Piotroski F 3 of 9 middling 2000Beneish M not enough filed detail (needs receivables, cost of revenue, PP&E, depreciation, SG&A for two years)Sloan accruals -19% earnings backed by cash 1996DuPont ROE -131% = margin -6.6% × turns 3.95 × leverage 5.03

What a terminal subscription used to buy, a filing and arithmetic now give anyone. Published method, from the same filings. Display only: nothing here moves the range or its receipt. Why? →

Health Harboragilon health sails as Old boat3 warning signs

Health watch · 12 monthsDirector or officer change ×3

Versus peersoperating margin −7.8% vs a 2.0% median · revenue growth −2.1% vs 13.0% · cash beats 5% of its size class · growth beats 96% 54 services-misc health & allied services, nec filers

Trend · last year to this▼operating margin −4.8% → −7.8% · ▼revenue $6.1B → $5.9B · 5-year revenue: $1.5B · $2.4B · $4.3B · $6.1B · $5.9B

See all 24 services-misc health & allied services, nec companies on POPS4 sorted from the newest ship to the boat at the dock
#CompanyConditionOperating marginRevenue growthSales
1New shipTenet HealthcareTHCNew ship16.5%3.1%$21.3B
2New shipConcentra Group Holdings ParentCONNew ship15.4%13.9%$2.2B
3New shipSurgery PartnersSGRYNew ship11.8%6.2%$3.3B
4New shipAveanna Healthcare HoldingsAVAHNew ship10.5%20.2%$2.4B
5New shipAddus HomeCareADUSNew ship9.7%23.2%$1.4B
6New shipOption Care HealthOPCHNew ship6.0%13.0%$5.6B
7New shipHims & Hers HealthHIMSNew ship4.5%59.0%$2.3B
8New shipArdent HealthARDTNew ship—6.0%$6.3B
9New shipHealthcare Services GroupHCSGNew ship—7.1%$1.8B
10Sound shipPacs GroupPACSSound ship5.9%29.3%$5.3B
11Sound shipAdaptHealthAHCOSound ship2.8%−0.5%$3.2B
12Sound shipTeladoc HealthTDOCSound ship−10.4%−1.5%$2.5B
13Sound shipSonida Senior LivingSNDASound ship—25.2%$381.1M
14Sound shipHca HealthcareHCASound ship—7.1%$75.6B
15Weathered boatCardiff LexingtonCDIXWeathered boat9.5%39.5%$11.5M
16Weathered boatCryo-Cell InternationalCCELWeathered boat1.5%−1.3%$31.6M
17Weathered boatLifemdLFMDWeathered boat−4.0%25.3%$194.1M
18Old boatAirSculpt TechnologiesAIRSOld boat−7.6%−15.8%$151.8M
19Rotting at the dockStarling OncologySTLNRotting at the dock−7.2%27.8%$502.7M
20Rotting at the dockMarpaiMRAIRotting at the dock−74.9%−35.8%$18.1M
21Rotting at the dockBioCorRxBICXRotting at the dock−606.0%10301.1%$0.8M
22Rotting at the dockMangoceuticalsMGRXRotting at the dock−3954.3%−26.0%$0.5M
23Rotting at the dockBiorestorative TherapiesBRTXRotting at the dock−4350.1%−10.3%$0.4M
24Rotting at the dockEdgemodeEDGMRotting at the dock——$0.0M

From each company’s own POPS4 card. Green beats the industry median above, red trails it. Not a rating and not investment advice.

Sailing speed follows growth: 35.4% a year crosses the harbor in 30 seconds.

🌊 Visit the Bay →
The warning signs
  • Operating cash flow was negative
  • Operating loss a margin of -7.8% in FY2025
  • Revenue is hard to predict its 80% range is ±29%

Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an operating loss; negative free cash flow outside regulated utilities; an 80% revenue range of ±25% or wider. A picture of the signs, not a rating and not investment advice.

Brand success factors · calendar 2025

The Trillion Score: 512

Exponential Success Score

Built on over $200 trillion of sworn revenue, 13 years of data, 770,002 figures. Sealed by Edgarette.

How The Trillion Score works. We read eight measures of success from agilon health's own SEC filings and test each one against the public companies in its field, here other health & allied services. The longer and fuller the record, the more weight those results carry. A model built on past filings then turns them into the odds of thriving, which means outgrowing the field for three years without a severe decline. A score of 500 is about average, and every 100 points doubles the odds. Every company is ranked on this same scale.

What it says here. At 512, agilon health's odds of thriving come to 38%, against about 37% for the typical filer. It meets 2 of 5 success points.

512The Trillion Score
38%modeled odds of thriving over three years
HighFall Risk
#2 of 7rank in its field
#1,194 of 2,824rank across all filers

What the score means

The higher the score, the more often companies went on to thrive. At this level, about 38 of every 100 did.

31%Under 45035%450 to 49938%500 to 549This company: 51244%550 to 59957%600 and up

Share of companies that beat their field for three years with no severe decline, tested on 2019 to 2022 filings.

Fall Risk: High

Separate from the score, this asks what could go wrong: the odds of sales falling 30% or the filings stopping within three years. In the tests, about 41 of every 100 companies in the High band did. That is the group's history, not a forecast for this company.

MoneyIt burned about 2 cents of free cash on each sales dollar after paying for its plants and equipment. Its cash would cover that burn for about 1.5 years. It holds more cash than debt.cash negative over five years
SwingsIn its worst fifth of years, sales fell about 2% a year.-2.1% a year
Filed eventsIn the last two years it told the SEC about 1 filings on restatements, delisting notices, bankruptcy or debt defaults, and 4 filings on leadership or auditor changes.5

The eight success points

PointWhat it meansPlace in field
SpeedSales grew faster than most of its field.100 of 100Met
SteadinessGrowth swung a lot for what it delivered.57 of 100Not yet
Price premiumIt keeps less of each sales dollar than the leaders in its field.33 of 100Not yet
Margin stays above the fieldIts margin has not held above the field for long.0 of 100Not yet
Moat half-lifeNot filed.
Brand spend yieldNot filed.
Learning curveNot filed.
Climb in the fieldIt has been moving up the size ranks in its field.100 of 100Met

The actuarial view

CredibilityWith 7 years of filings, the record earns 42% of the weight. The rest stays at the middle of the field.0.42
Severe decline, class CAbout 30 of every 100 companies with this many points fell 30% or stopped reporting within three years.30.1%
Actual vs expectedSales are 98% higher than if it had simply kept pace with its field.1.98

Top of its field: #1 Viemed Healthcare · #2 agilon health · #3 Cryo Cell International · #4 Davita · #5 Sotera Health

Ranked by The Trillion Score. See the method and score your own brand. Tested on 2019 to 2022 filings. Odds, class and Fall Risk figures are the experience of similar filers, not a forecast for this company. A statistical description of past filings, not a rating or advice.

Recent filings
Measured, not prophesiedSuccess tools: score it, compare it, see its fieldFour questions. Scored against the SEC filings of the companies in your field.

Try InstagramSpriteHokaDisneyGatoradee.l.f.

Each benchmark is the median of SEC filers in your industry code, from their own audited filings, read on the filing boards. Reporting, not investment advice.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price. Reporting, not investment advice. No price targets and no trading recommendations. Figures from the SEC’s own data · every filing · this page as JSON · Open in Excel (CSV) · Ten-year table (CSV) ·

1 · Follow

Follow their filings

Or tap watch on any row above. You get the company’s live filing feed and Edgar’s card. Nothing to sign up for.

On Bluesky: follow Edgar & Edgarette.

2 · Price it

A new leader’s rebrand and launch

Priced live by the same engine as our estimator, from the catalogue at wholesale.

Price the printing · Open the full estimator

✦ Build the kit yourself
3 · Confirm

Check it with Jenny

Most buyers check what they found, or what their AI found, with one person before they commit. That person is the principal.

Jenny Huang Goodman MPA MSc MHSA, Principal

Book a time info@pops4.com
Independence. Every range, flag and score on these boards is identical for everyone. Clients of POPS4 or Hako Shikin receive no different numbers, no earlier access and no say in what is published. The service lines shown beside each board describe work we do; they never change the data. For reviewers: Method · Terms of use · Status
Free · unsponsored · source-linked

Clean data. No ads. Not now, not later.

Nine boards reading every SEC filing the business day after it lands, from the settled SEC daily index, ten editorial desks publishing daily, an open endpoint other AIs can query, and a 70,000-product house behind all of it. This is the public record end of it.

Every row is a filing.Straight from the company's own SEC document, linked. Nothing written, nothing inferred.
Nobody is watching you read.No ad trackers, no cookies from us. Our page counts are cookieless.
One email, one job.Watch a company and we hold that address for the alert alone. One tap ends it. Never shared, never passed on.
The house pays for this.Corporate event programs, corporate supplies and branded merchandise, since 1997. That is what funds the desks, under the house's own vendor standards.
Free to reuse with credit · CC BY 4.0 · how the boards are built
Data & Disclosure Notice: Edgar and Edgarette are automated software. Every figure on this page is calculated by software from public filings made by companies and funds with the U.S. Securities and Exchange Commission (EDGAR) and is published without individual human review. The accuracy and completeness of those filings are the responsibility of the filers; reports can contain errors and can be amended. Figures are shown as filed and as of each filing's date, and this page may be corrected or updated without notice. Ranges, expected returns, rankings, boats and other measures are statistical descriptions of past filings, not ratings, price forecasts, company guidance or recommendations; past results do not guarantee future results. This is general information published for all readers, not advice tailored to any person's portfolio, needs or circumstances, and nothing here is financial, investment, actuarial, legal, tax or other professional advice. Actuaries and other professionals who use these figures remain responsible for reviewing them for reasonableness and consistency against the original filings and for disclosing their reliance on them. No company, fund or reinsurer pays to be included or ranked. Provided as is, without warranty of any kind. Not affiliated with or endorsed by the SEC or by any company, fund or reinsurer named. All trademarks remain the property of their owners.